Salim Yusuf

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Geographic Areas

Canada

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Granger Bradi B; Ekman Inger; Granger Christopher B; Ostergren Jan; Olofsson Bertil; Michelson Eric; McMurray John J V; Yusuf Salim; Pfeffer Marc A; Swedberg Karl
Adherence to medication according to sex and age in the CHARM programme.
Bath Philip M W; Martin Reneé H; Palesch Yuko; Cotton Daniel; Yusuf Salim; Sacco Ralph; Diener Hans-Christoph; Toni Danilo; Estol Conrado; Roberts Robin;
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
Hegele Robert A; Ban Matthew R; Hsueh Neil; Kennedy Brooke A; Cao Henian; Zou Guang Yong; Anand Sonia; Yusuf Salim; Huff Murray W; Wang Jian
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Salim Yusuf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Granger Bradi B; Ekman Inger; Granger Christopher B; Ostergren Jan; Olofsson Bertil; Michelson Eric; McMurray John J V; Yusuf Salim; Pfeffer Marc A; Swedberg Karl
Adherence to medication according to sex and age in the CHARM programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(11):1092-8.
2009: Bath Philip M W; Martin Reneé H; Palesch Yuko; Cotton Daniel; Yusuf Salim; Sacco Ralph; Diener Hans-Christoph; Toni Danilo; Estol Conrado; Roberts Robin;
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
Stroke; a journal of cerebral circulation 2009;40(11):3541-6.
2009: Hegele Robert A; Ban Matthew R; Hsueh Neil; Kennedy Brooke A; Cao Henian; Zou Guang Yong; Anand Sonia; Yusuf Salim; Huff Murray W; Wang Jian
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.
Human molecular genetics 2009;18(21):4189-94.
2009: Teo K K; Liu L; Chow C K; Wang X; Islam S; Jiang L; Sanderson J E; Rangarajan S; Yusuf S;
Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study.
Heart (British Cardiac Society) 2009;95(22):1857-64.
2009: Karthikeyan Ganesan; Moncur Ross A; Levine Oren; Heels-Ansdell Diane; Chan Matthew T V; Alonso-Coello Pablo; Yusuf Salim; Sessler Daniel; Villar Juan Carlos; Berwanger Otavio; McQueen Matthew; Mathew Anna; Hill Stephen; Gibson Simon; Berry Colin; Yeh Huei-Ming; Devereaux P J
Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.
Journal of the American College of Cardiology 2009;54(17):1599-606.
2009: Morrison Katherine M; Atkinson Stephanie A; Yusuf Salim; Bourgeois Jacqueline; McDonald Sarah; McQueen Matthew J; Persadie Richard; Hunter Barry; Pogue Janice; Teo Koon;
The Family Atherosclerosis Monitoring In earLY life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis.
American heart journal 2009;158(4):533-9.
2009: Verdecchia Paolo; Sleight Peter; Mancia Giuseppe; Fagard Robert; Trimarco Bruno; Schmieder Roland E; Kim Jae-Hyung; Jennings Garry; Jansky Petr; Chen Jyh-Hong; Liu Lisheng; Gao Peggy; Probstfield Jeffrey; Teo Koon; Yusuf Salim;
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.
Circulation 2009;120(14):1380-9.
2009: Lanktree Matthew B; Hegele Robert A; Yusuf Salim; Anand Sonia S
Multi-ethnic genetic association study of carotid intima-media thickness using a targeted cardiovascular SNP microarray.
Stroke; a journal of cerebral circulation 2009;40(10):3173-9.
2009: Connolly Stuart J; Ezekowitz Michael D; Yusuf Salim; Eikelboom John; Oldgren Jonas; Parekh Amit; Pogue Janice; Reilly Paul A; Themeles Ellison; Varrone Jeanne; Wang Susan; Alings Marco; Xavier Denis; Zhu Jun; Diaz Rafael; Lewis Basil S; Darius Harald; Diener Hans-Christoph; Joyner Campbell D; Wallentin Lars;
Dabigatran versus warfarin in patients with atrial fibrillation.
The New England journal of medicine 2009;361(12):1139-51.
2009: Liu Xin; Wang Xingyu; Shen Yue; Wu Lijun; Ruan Xiaoyang; Lindpaintner Klaus; Yusuf Salim; Engert James C; Anand Sonia; Tan Xuerui; Liu Lisheng
The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population.
Atherosclerosis 2009;206(1):199-203.
2009: Jackson Colette E; Solomon Scott D; Gerstein Hertzel C; Zetterstrand Sofia; Olofsson Bertil; Michelson Eric L; Granger Christopher B; Swedberg Karl; Pfeffer Marc A; Yusuf Salim; McMurray John J V;
Albuminuria in chronic heart failure: prevalence and prognostic importance.
Lancet 2009;374(9689):543-50.
2009: Jolly Sanjit S; Faxon David P; Fox Keith A A; Afzal Rizwan; Boden William E; Widimsky Petr; Steg P Gabriel; Valentin Vicent; Budaj Andrez; Granger Christopher B; Joyner Campbell D; Chrolavicius Susan; Yusuf Salim; Mehta Shamir R
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.
Journal of the American College of Cardiology 2009;54(5):468-76.
2009: McMurray John J V; Granger Christopher B; Ostergren Jan; Yusuf Salim; Pfeffer Marc A; Swedberg Karl
Dual renin-angiotensin system blockade in heart failure.
Journal of the American College of Cardiology 2009;54(3):278; author reply 279-80.
2009: Teo Koon; Chow Clara K; Vaz Mario; Rangarajan Sumathy; Yusuf Salim;
The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries.
American heart journal 2009;158(1):1-7.e1.
2009: Sleight Peter; Redon Josep; Verdecchia Paolo; Mancia Giuseppe; Gao Peggy; Fagard Robert; Schumacher Helmut; Weber Michael; Böhm Michael; Williams Bryan; Pogue Janice; Koon Teo; Yusuf Salim;
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.
Journal of hypertension 2009;27(7):1360-9.
2009: Mann Johannes F E; Schmieder Roland E; Dyal Leanne; McQueen Matthew J; Schumacher Helmut; Pogue Janice; Wang Xingyu; Probstfield Jeffrey L; Avezum Alvaro; Cardona-Munoz Ernesto; Dagenais Gilles R; Diaz Rafael; Fodor George; Maillon Jean M; Rydén Lars; Yu Cheuk M; Teo Koon K; Yusuf Salim;
Effect of telmisartan on renal outcomes: a randomized trial.
Annals of internal medicine 2009;151(1):1-10, W1-2.
2009: Cowan Brett R; Young Alistair A; Anderson Craig; Doughty Robert N; Krittayaphong Rungroj; Lonn Eva; Marwick Thomas H; Reid Chris M; Sanderson John E; Schmieder Roland E; Teo Koon; Wadham Angela K; Worthley Stephen G; Yu Cheuk-Man; Yusuf Salim; Jennings Garry L
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(7):421-33.
2009: Lanktree Matthew B; Anand Sonia S; Yusuf Salim; Hegele Robert A;
Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample.
Journal of lipid research 2009;50(7):1487-96.
2009: Pogue Janice; Walter Stephen D; Yusuf Salim
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
Clinical trials (London, England) 2009;6(3):239-51.
2009: Lonn Eva M; Gerstein Hertzel C; Sheridan Patrick; Smith Sandra; Diaz Rafael; Mohan Viswanathan; Bosch Jackie; Yusuf Salim; Dagenais Gilles R;
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Journal of the American College of Cardiology 2009;53(22):2028-35.
2009: Motlagh Bahareh; O'Donnell Martin; Yusuf Salim
Prevalence of cardiovascular risk factors in the Middle East: a systematic review.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(3):268-80.
2009: Mehta Shamir R; Granger Christopher B; Boden William E; Steg Philippe Gabriel; Bassand Jean-Pierre; Faxon David P; Afzal Rizwan; Chrolavicius Susan; Jolly Sanjit S; Widimsky Petr; Avezum Alvaro; Rupprecht Hans-Jurgen; Zhu Jun; Col Jacques; Natarajan Madhu K; Horsman Craig; Fox Keith A A; Yusuf Salim;
Early versus delayed invasive intervention in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2165-75.
2009: Ezekowitz Michael D; Connolly Stuart; Parekh Amit; Reilly Paul A; Varrone Jeanne; Wang Susan; Oldgren Jonas; Themeles Ellison; Wallentin Lars; Yusuf Salim
Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.
American heart journal 2009;157(5):805-10, 810.e1-2.
2009: Connolly Stuart J; Pogue Janice; Hart Robert G; Hohnloser Stefan H; Pfeffer Marc; Chrolavicius Susan; Yusuf Salim
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
The New England journal of medicine 2009;360(20):2066-78.
2009: Preiss David; Zetterstrand Sofia; McMurray John J V; Ostergren Jan; Michelson Eric L; Granger Christopher B; Yusuf Salim; Swedberg Karl; Pfeffer Marc A; Gerstein Hertzel C; Sattar Naveed;
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Diabetes care 2009;32(5):915-20.
2009: Yusuf Salim; Lonn Eva; Bosch Jackie
Lipid lowering for primary prevention.
Lancet 2009;373(9670):1152-5.
2009: Goyal Abhinav; Mehta Shamir R; Gerstein Hertzel C; Díaz Rafael; Afzal Rizwan; Xavier Denis; Zhu Jun; Pais Prem; Lisheng Liu; Kazmi Khawar A; Zubaid Mohammad; Piegas Leopoldo S; Widimsky Petr; Budaj Andrzej; Avezum Alvaro; Yusuf Salim
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
American heart journal 2009;157(4):763-70.
2009: White Michel; Rouleau Jean-Lucien; Afzal Rizwan; Floras John; Yusuf Salim; McKelvie Robert S
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
Therapeutic advances in cardiovascular disease 2009;3(2):113-21.
2009: O'Donnell Martin; Yusuf Salim
Tackling the global burden of stroke: the need for large-scale international studies.
Lancet neurology 2009;8(4):306-7.
2009: Jolly Sanjit S; Pogue Janice; Haladyn Kimberly; Peters Ron J G; Fox Keith A A; Avezum Alvaro; Gersh Bernard J; Rupprecht Hans Jurgen; Yusuf Salim; Mehta Shamir R
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
European heart journal 2009;30(8):900-7.
2009: Joyner Campbell D; Peters Ron J G; Afzal Rizwan; Chrolavicius Susan; Mehta Shamir R; Fox Keith A A; Granger Christopher B; Franzosi Maria Grazia; Flather Marcus; Budaj Andrzej; Bassand Jean-Pierre; Yusuf Salim
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
American heart journal 2009;157(3):502-8.
2009: Cukierman-Yaffe Tali; Gerstein Hertzel C; Anderson Craig; Zhao Feng; Sleight Peter; Hilbrich Lutz; Jackson Stephen H D; Yusuf Salim; Teo Koon;
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
Diabetes research and clinical practice 2009;83(3):387-93.
2009: Budaj Andrzej; Eikelboom John W; Mehta Shamir R; Afzal Rizwan; Chrolavicius Susan; Bassand Jean-Pierre; Fox Keith A A; Wallentin Lars; Peters Ron J G; Granger Christopher B; Joyner Campbell D; Yusuf Salim;
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.
European heart journal 2009;30(6):655-61.
2009: Burman Debika; Mente Andrew; Hegele Robert A; Islam Shofiqul; Yusuf Salim; Anand Sonia S
Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada.
Atherosclerosis 2009;203(1):192-200.
2009: Allen Larry A; Felker G Michael; Pocock Stuart; McMurray John J V; Pfeffer Marc A; Swedberg Karl; Wang Duolao; Yusuf Salim; Michelson Eric L; Granger Christopher B;
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(2):170-7.
2009: Xavier Denis; Pais Prem; Sigamani Alben; Pogue Janice; Afzal Rizwan; Yusuf Salim;
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.
Nature clinical practice. Cardiovascular medicine 2009;6(2):96-7.
2009: Abrahamsson Putte; Dobson Joanna; Granger Christopher B; McMurray John J V; Michelson Eric L; Pfeffer Marc; Pocock Stuart; Solomon Scott D; Yusuf Salim; Swedberg Karl;
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.
European heart journal 2009;30(3):338-45.
2009: Karthikeyan Ganesan; Teo Koon K; Islam Shofiqul; McQueen Mathew J; Pais Prem; Wang Xingyu; Sato Hiroshi; Lang Chim Choy; Sitthi-Amorn Chitr; Pandey M R; Kazmi Khawar; Sanderson John E; Yusuf Salim
Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study.
Journal of the American College of Cardiology 2009;53(3):244-53.
2009: Yusuf Salim; Natarajan Madhu; Karthikeyan Ganesan; Taggart David
Management of stable angina.
BMJ (Clinical research ed.) 2009;339():b2789.
2009: Vaz Mario; Bharathi Ankalmadagu Venkatasubbareddy; Thomas Tinku; Yusuf Salim; Kurpad Anura Vishwanath
The repeatability of self reported physical activity patterns in rural South India.
Asia Pacific journal of clinical nutrition 2009;18(1):71-5.
2008: Meredith Peter A; Ostergren Jan; Anand Inder; Puu Margareta; Solomon Scott D; Michelson Eric L; Olofsson Bertil; Granger Christopher B; Yusuf Salim; Swedberg Karl; Pfeffer Marc A; McMurray John J V
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
Journal of the American College of Cardiology 2008;52(24):2000-7.
2008: Mehta Shamir R; Bassand Jean-Pierre; Chrolavicius Susan; Diaz Rafael; Fox Keith A A; Granger Christopher B; Jolly Sanjit; Rupprecht Hans-Jurgen; Widimsky Petr; Yusuf Salim;
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
American heart journal 2008;156(6):1080-1088.e1.
2008: Cunningham Solveig Argeseanu; Mitchell Kristina; Narayan K M; Yusuf Salim
Doctors' strikes and mortality: a review.
Social science & medicine (1982) 2008;67(11):1784-8.
2008: McDonald Sarah D; Malinowski Ann; Zhou Qi; Yusuf Salim; Devereaux Philip J
Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.
American heart journal 2008;156(5):918-30.
2008: Connolly Stuart J; Pogue Janice; Eikelboom John; Flaker Gregory; Commerford Patrick; Franzosi Maria Grazia; Healey Jeffrey S; Yusuf Salim;
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Circulation 2008;118(20):2029-37.
2008: Mehta Shamir R; Boden William E; Eikelboom John W; Flather Marcus; Steg P Gabriel; Avezum Alvaro; Afzal Rizwan; Piegas Leopoldo S; Faxon David P; Widimsky Petr; Budaj Andrzej; Chrolavicius Susan; Rupprecht Hans-Jurgen; Jolly Sanjit; Granger Christopher B; Fox Keith A A; Bassand Jean-Pierre; Yusuf Salim;
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Circulation 2008;118(20):2038-46.
2008: Held Claes; Sumner Glen; Sheridan Patrick; McQueen Mathew; Smith Sandra; Dagenais Gilles; Yusuf Salim; Lonn Eva
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
Vascular medicine (London, England) 2008;13(4):245-53.
2008: Iqbal Romaina; Anand Sonia; Ounpuu Stephanie; Islam Shofiqul; Zhang Xiaohe; Rangarajan Sumathy; Chifamba Jephat; Al-Hinai Ali; Keltai Matyas; Yusuf Salim;
Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study.
Circulation 2008;118(19):1929-37.
2008: Pocock Stuart J; McMurray John J V; Dobson Joanna; Yusuf Salim; Granger Christopher B; Michelson Eric L; Ostergren Jan; Pfeffer Marc A; Solomon Scott D; Anker Stefan D; Swedberg Karl B
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
European heart journal 2008;29(21):2641-50.
2008: Wang Jian; Ban Matthew R; Kennedy Brooke A; Anand Sonia; Yusuf Salim; Huff Murray W; Pollex Rebecca L; Hegele Robert A
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Nature clinical practice. Cardiovascular medicine 2008;5(11):730-7.
2008: de Koning Lawrence; Merchant Anwar T; Hegele Robert A; Xie Changchun; Vuksan Vlad; Teo Koon; Yusuf Salim; Anand Sonia S;
Association of the FABP2 T54 variant with plasma triglycerides and insulin resistance in a multiethnic population.
Clinical chemistry 2008;54(10):1742-4.
2008: Wang Jian; Ban Matthew R; Zou Guang Yong; Cao Henian; Lin Tim; Kennedy Brooke A; Anand Sonia; Yusuf Salim; Huff Murray W; Pollex Rebecca L; Hegele Robert A
Polygenic determinants of severe hypertriglyceridemia.
Human molecular genetics 2008;17(18):2894-9.
2008: Mann Johannes F E; Schmieder Roland E; McQueen Matthew; Dyal Leanne; Schumacher Helmut; Pogue Janice; Wang Xingyu; Maggioni Aldo; Budaj Andrzej; Chaithiraphan Suphachai; Dickstein Kenneth; Keltai Matyas; Metsärinne Kaj; Oto Ali; Parkhomenko Alexander; Piegas Leopoldo S; Svendsen Tage L; Teo Koon K; Yusuf Salim;
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Lancet 2008;372(9638):547-53.
2008: Gerstein Hertzel C; Swedberg Karl; Carlsson Jonas; McMurray John J V; Michelson Eric L; Olofsson Bertil; Pfeffer Marc A; Yusuf Salim;
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Archives of internal medicine 2008;168(15):1699-704.
2008: McDonald Sarah D; Yusuf Salim; Sheridan Patrick; Anand Sonia S; Gerstein Hertzel C;
Dysglycemia and a history of reproductive risk factors.
Diabetes care 2008;31(8):1635-8.
2008: McQueen Matthew J; Hawken Steven; Wang Xingyu; Ounpuu Stephanie; Sniderman Allan; Probstfield Jeffrey; Steyn Krisela; Sanderson John E; Hasani Mohammad; Volkova Emilia; Kazmi Khawar; Yusuf Salim;
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.
Lancet 2008;372(9634):224-33.
2008: Marin-Neto Jose Antonio; Rassi Anis; Morillo Carlos A; Avezum Alvaro; Connolly Stuart J; Sosa-Estani Sergio; Rosas Fernando; Yusuf Salim;
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
American heart journal 2008;156(1):37-43.
2008: Werner Christian; Baumhäkel Magnus; Teo Koon K; Schmieder Roland; Mann Johannes; Unger Thomas; Yusuf Salim; Böhm Michael
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(7):418-31.
2008: MacDonald Michael R; Petrie Mark C; Varyani Fumi; Ostergren Jan; Michelson Eric L; Young James B; Solomon Scott D; Granger Christopher B; Swedberg Karl; Yusuf Salim; Pfeffer Marc A; McMurray John J V;
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2008;29(11):1377-85.
2008: Devereaux P J; Yang Homer; Yusuf Salim; Guyatt Gordon; Leslie Kate; Villar Juan Carlos; Xavier Denis; Chrolavicius Susan; Greenspan Launi; Pogue Janice; Pais Prem; Liu Lisheng; Xu Shouchun; Málaga German; Avezum Alvaro; Chan Matthew; Montori Victor M; Jacka Mike; Choi Peter
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
Lancet 2008;371(9627):1839-47.
2008: Healey Jeff S; Hart Robert G; Pogue Janice; Pfeffer Marc A; Hohnloser Stefan H; De Caterina Raffaele; Flaker Greg; Yusuf Salim; Connolly Stuart J
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Stroke; a journal of cerebral circulation 2008;39(5):1482-6.
2008: Dagenais G R; Gerstein H C; Holman R; Budaj A; Escalante A; Hedner T; Keltai M; Lonn E; McFarlane S; McQueen M; Teo K; Sheridan P; Bosch J; Pogue J; Yusuf S
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Diabetes care 2008;31(5):1007-14.
2008: Xavier Denis; Pais Prem; Devereaux P J; Xie Changchun; Prabhakaran D; Reddy K Srinath; Gupta Rajeev; Joshi Prashant; Kerkar Prafulla; Thanikachalam S; Haridas K K; Jaison T M; Naik Sudhir; Maity A K; Yusuf Salim;
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.
Lancet 2008;371(9622):1435-42.
2008: Yusuf Salim; Teo Koon K; Pogue Janice; Dyal Leanne; Copland Ingrid; Schumacher Helmut; Dagenais Gilles; Sleight Peter; Anderson Craig
Telmisartan, ramipril, or both in patients at high risk for vascular events.
The New England journal of medicine 2008;358(15):1547-59.
2008: Anand Sonia S; Islam Shofiqul; Rosengren Annika; Franzosi Maria Grazia; Steyn Krisela; Yusufali Afzal Hussein; Keltai Matyas; Diaz Rafael; Rangarajan Sumathy; Yusuf Salim;
Risk factors for myocardial infarction in women and men: insights from the INTERHEART study.
European heart journal 2008;29(7):932-40.
2008: Xavier Denis; Devereaux P J; Goyal Abhinav; Pais Prem; Yusuf Salim
Polypharmacotherapy for primary prevention of cardiovascular disease.
Indian heart journal 2008;60(2 Suppl B):B29-33.
2008: Taggart David P; Kaul Sanjay; Boden William E; Ferguson T Bruce; Guyton Robert A; Mack Michael J; Sergeant Paul T; Shemin Richard J; Smith Peter K; Yusuf Salim
Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.
Journal of the American College of Cardiology 2008;51(9):885-92.
2008: Peters Ron J G; Joyner Campbell; Bassand Jean-Pierre; Afzal Rizwan; Chrolavicius Susan; Mehta Shamir R; Oldgren Jonas; Wallentin Lars; Budaj Andrzej; Fox Keith A; Yusuf Salim;
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
European heart journal 2008;29(3):324-31.
2008: Weir R A P; McMurray John J V; Puu Margareta; Solomon Scott D; Olofsson Bertil; Granger Christopher B; Yusuf Salim; Michelson Eric L; Swedberg Karl; Pfeffer Marc A;
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(2):157-63.
2008: Oldgren Jonas; Wallentin Lars; Afzal Rizwan; Bassand Jean-Pierre; Budaj Andrzej; Chrolavicius Susan; Fox Keith A A; Granger Christopher B; Mehta Shamir R; Pais Prem; Peters Ron J G; Xavier Denis; Zhu Jun; Yusuf Salim;
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
European heart journal 2008;29(3):315-23.
2008: Mann Johannes F E; Sheridan Patrick; McQueen Matthew J; Held Claes; Arnold J Malcolm O; Fodor George; Yusuf Salim; Lonn Eva M;
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):645-53.
2008: Merchant Anwar T; Kelemen Linda E; de Koning Lawrence; Lonn Eva; Vuksan Vlad; Jacobs Ruby; Davis Bonnie; Teo Koon K; Yusuf Salim; Anand Sonia S;
Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis.
The American journal of clinical nutrition 2008;87(1):168-74.
2008: Origin Trial Investigators; Gerstein Hertzel; Yusuf Salim; Riddle Matthew C; Ryden Lars; Bosch Jackie
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
American heart journal 2008;155(1):26-32, 32.e1-6.
2008: Bharathi Ankalmadagu Venkatasubbareddy; Kurpad Anura Vishwanath; Thomas Tinku; Yusuf Salim; Saraswathi Govindachar; Vaz Mario
Development of food frequency questionnaires and a nutrient database for the Prospective Urban and Rural Epidemiological (PURE) pilot study in South India: methodological issues.
Asia Pacific journal of clinical nutrition 2008;17(1):178-85.
2008: Al-Attar Salam A; Pollex Rebecca L; Ban Matthew R; Young T Kue; Bjerregaard Peter; Anand Sonia S; Yusuf Salim; Zinman Bernard; Harris Stewart B; Hanley Anthony Jg; Connelly Philip W; Huff Murray W; Hegele Robert A
Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.
Cardiovascular diabetology 2008;7():5.
2008: Duley Lelia; Antman Karen; Arena Joseph; Avezum Alvaro; Blumenthal Mel; Bosch Jackie; Chrolavicius Sue; Li Timoa; Ounpuu Stephanie; Perez Analia Cristina; Sleight Peter; Svard Robbyna; Temple Robert; Tsouderous Yannis; Yunis Carla; Yusuf Salim
Specific barriers to the conduct of randomized trials.
Clinical trials (London, England) 2008;5(1):40-8.
2008: Yusuf Salim; Bosch Jackie; Devereaux Philip J; Collins Rory; Baigent Colin; Granger Christopher; Califf Robert; Temple Robert
Sensible guidelines for the conduct of large randomized trials.
Clinical trials (London, England) 2008;5(1):38-9.
2008: Serre David; Montpetit Alexandre; Paré Guillaume; Engert James C; Yusuf Salim; Keavney Bernard; Hudson Thomas J; Anand Sonia
Correction of population stratification in large multi-ethnic association studies.
PloS one 2008;3(1):e1382.
2007: Gerstein Hertzel C; Yusuf Salim
Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
Nature clinical practice. Endocrinology & metabolism 2007;3(12):798-9.
2007: Anand Sonia S; Davis A Darlene; Ahmed Rashid; Jacobs Ruby; Xie Changchun; Hill Amber; Sowden Joon; Atkinson Stephanie; Blimkie Cameron; Brouwers Melissa; Morrison Katherine; de Koning Larry; Gerstein Hertzel; Yusuf Salim;
A family-based intervention to promote healthy lifestyles in an aboriginal community in Canada.
Canadian journal of public health. Revue canadienne de santé publique 2007;98(6):447-52.
2007: Díaz Rafael; Goyal Abhinav; Mehta Shamir R; Afzal Rizwan; Xavier Denis; Pais Prem; Chrolavicius Susan; Zhu Jun; Kazmi Khawar; Liu Lisheng; Budaj Andrzej; Zubaid Mohammad; Avezum Alvaro; Ruda Mikhail; Yusuf Salim
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
JAMA : the journal of the American Medical Association 2007;298(20):2399-405.
2007: Hohnloser Stefan H; Pajitnev Dimitri; Pogue Janice; Healey Jeff S; Pfeffer Marc A; Yusuf Salim; Connolly Stuart J;
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Journal of the American College of Cardiology 2007;50(22):2156-61.
2007: Desai Akshay S; Swedberg Karl; McMurray John J V; Granger Christopher B; Yusuf Salim; Young James B; Dunlap Mark E; Solomon Scott D; Hainer James W; Olofsson Bertil; Michelson Eric L; Pfeffer Marc A;
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
Journal of the American College of Cardiology 2007;50(20):1959-66.
2007: Ray J G; Lonn E; Yi Q; Rathe A; Sheridan P; Kearon C; Yusuf S; Arnold M J O; McQueen M J; Pogue J; Probstfield J; Fodor G; Held C; Micks M; Genest J
Venous thromboembolism in association with features of the metabolic syndrome.
QJM : monthly journal of the Association of Physicians 2007;100(11):679-84.
2007: Wang Jian; Cao Henian; Ban Matthew R; Kennedy Brooke A; Zhu Siqi; Anand Sonia; Yusuf Salim; Pollex Rebecca L; Hegele Robert A
Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650).
Arteriosclerosis, thrombosis, and vascular biology 2007;27(11):2450-5.
2007: Mehta Shamir R; Granger Christopher B; Eikelboom John W; Bassand Jean-Pierre; Wallentin Lars; Faxon David P; Peters Ron J G; Budaj Andrzej; Afzal Rizwan; Chrolavicius Susan; Fox Keith A A; Yusuf Salim
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
Journal of the American College of Cardiology 2007;50(18):1742-51.
2007: Yusuf Salim; Fallen Ernest; Harrington Robert A; Guyton Robert A
Clinical decisions. Management of stable coronary disease.
The New England journal of medicine 2007;357(17):1762-6.
2007: Alegria Jorge R; Miller Todd D; Gibbons Raymond J; Yi Qi-Long; Yusuf Salim;
Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.
American heart journal 2007;154(4):743-50.
2007: Sanderson John E; Mayosi Bongani; Yusuf Salim; Reddy Srinath; Hu Shengshou; Chen Zhengming; Timmis Adam
Global burden of cardiovascular disease.
Heart (British Cardiac Society) 2007;93(10):1175.
2007: Friedewald Vincent E; Bates Eric R; Granger Christopher B; Yusuf Salim; Roberts William C
The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
The American journal of cardiology 2007;100(6):974-80.
2007: Fox Keith A A; Bassand Jean-Pierre; Mehta Shamir R; Wallentin Lars; Theroux Pierre; Piegas Leopoldo Soares; Valentin Vicent; Moccetti Tiziano; Chrolavicius Susan; Afzal Rizwan; Yusuf Salim;
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
Annals of internal medicine 2007;147(5):304-10.
2007: Solomon Scott D; Dobson Joanna; Pocock Stuart; Skali Hicham; McMurray John J V; Granger Christopher B; Yusuf Salim; Swedberg Karl; Young James B; Michelson Eric L; Pfeffer Marc A;
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
Circulation 2007;116(13):1482-7.
2007: Salehian Omid; Healey Jeff; Stambler Bruce; Alnemer Khalid; Almerri Khalid; Grover John; Bata Iqbal; Mann Johannes; Matthew James; Pogue Janice; Yusuf Salim; Dagenais Gilles; Lonn Eva;
Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
American heart journal 2007;154(3):448-53.
2007: Kenchaiah Satish; Pocock Stuart J; Wang Duolao; Finn Peter V; Zornoff Leonardo A M; Skali Hicham; Pfeffer Marc A; Yusuf Salim; Swedberg Karl; Michelson Eric L; Granger Christopher B; McMurray John J V; Solomon Scott D;
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;116(6):627-36.
2007: Connolly Stuart J; Eikelboom John; O'Donnell Martin; Pogue Janice; Yusuf Salim
Challenges of establishing new antithrombotic therapies in atrial fibrillation.
Circulation 2007;116(4):449-55.
2007: Anand Sonia; Yusuf Salim; Xie Changchun; Pogue Janice; Eikelboom John; Budaj Andrzej; Sussex Bruce; Liu Lisheng; Guzman Randy; Cina Claudio; Crowell Richard; Keltai Matyas; Gosselin Gilbert
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
The New England journal of medicine 2007;357(3):217-27.
2007: Felker G Michael; Allen Larry A; Pocock Stuart J; Shaw Linda K; McMurray John J V; Pfeffer Marc A; Swedberg Karl; Wang Duolao; Yusuf Salim; Michelson Eric L; Granger Christopher B;
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
Journal of the American College of Cardiology 2007;50(1):40-7.
2007: Böhm Michael; Baumhäkel Magnus; Probstfield Jeffrey L; Schmieder Roland; Yusuf Salim; Zhao Feng; Koon Teo;
Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).
American heart journal 2007;154(1):94-101.
2007: Gohlke Helmut; Yusuf Salim
Quantitating loss of life by smoking a single cigarette.
Clinical research in cardiology : official journal of the German Cardiac Society 2007;96(7):522-3.
2007: Peters Ron J G; Mehta Shamir; Yusuf Salim
Acute coronary syndromes without ST segment elevation.
BMJ (Clinical research ed.) 2007;334(7606):1265-9.
2007: O'Meara Eileen; Clayton Tim; McEntegart Margaret B; McMurray John J V; Piña Ileana L; Granger Christopher B; Ostergren Jan; Michelson Eric L; Solomon Scott D; Pocock Stuart; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;115(24):3111-20.
2007: Gianni Monica; Bosch Jackie; Pogue Janice; Probstfield Jeffrey; Dagenais Gilles; Yusuf Salim; Lonn Eva
Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.
European heart journal 2007;28(11):1382-8.
2007: Gupta Diwakar; Natarajan Madhu Kailash; Gafni Amiram; Wang Lei; Shilton Don; Holder Douglas; Yusuf Salim
Capacity planning for cardiac catheterization: a case study.
Health policy (Amsterdam, Netherlands) 2007;82(1):1-11.
2007: Hilbrich Lutz; Truelsen Thomas; Yusuf Salim
Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development.
International journal of stroke : official journal of the International Stroke Society 2007;2(2):104-8.
2007: Hawkins Nathaniel M; Wang Duolao; McMurray John J V; Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Yusuf Salim; Pocock Stuart J; Ostergren Jan; Michelson Eric L; Dunn Francis G;
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(5):510-7.
2007: Keltai Mátyás; Tonelli Marcello; Mann Johannes F E; Sitkei Eva; Lewis Basil S; Hawken Steven; Mehta Shamir R; Yusuf Salim;
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(2):312-8.
2007: Razak Fahad; Anand Sonia S; Shannon Harry; Vuksan Vladimir; Davis Bonnie; Jacobs Ruby; Teo Koon K; McQueen Matthew; Yusuf Salim
Defining obesity cut points in a multiethnic population.
Circulation 2007;115(16):2111-8.
2007: Lanas Fernando; Avezum Alvaro; Bautista Leonelo E; Diaz Rafael; Luna Max; Islam Shofiqul; Yusuf Salim;
Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study.
Circulation 2007;115(9):1067-74.
2007: Held C; Gerstein H C; Yusuf S; Zhao F; Hilbrich L; Anderson C; Sleight P; Teo K;
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.
Circulation 2007;115(11):1371-5.
2007: Joshi Prashant; Islam Shofiqul; Pais Prem; Reddy Srinath; Dorairaj Prabhakaran; Kazmi Khawar; Pandey Mrigendra Raj; Haque Sirajul; Mendis Shanthi; Rangarajan Sumathy; Yusuf Salim
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries.
JAMA : the journal of the American Medical Association 2007;297(3):286-94.
2007: Merchant Anwar T; Anand Sonia S; Kelemen Linda E; Vuksan Vlad; Jacobs Ruby; Davis Bonnie; Teo Koon; Yusuf Salim;
Carbohydrate intake and HDL in a multiethnic population.
The American journal of clinical nutrition 2007;85(1):225-30.
2007: Lewis Eldrin F; Lamas Gervasio A; O'Meara Eileen; Granger Christopher B; Dunlap Mark E; McKelvie Robert S; Probstfield Jeffrey L; Young James B; Michelson Eric L; Halling Katarina; Carlsson Jonas; Olofsson Bertil; McMurray John J V; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(1):83-91.
2007: Hawkins N M; Wang D; McMurray J J V; Pfeffer M A; Swedberg K; Granger C B; Yusuf S; Pocock S J; Ostergren J; Michelson E L; Dunn F G;
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
Heart (British Cardiac Society) 2007;93(1):59-64.
2007: Pollex Rebecca L; Ban Matthew R; Young T Kue; Bjerregaard Peter; Anand Sonia S; Yusuf Salim; Zinman Bernard; Harris Stewart B; Hanley Anthony J G; Connelly Philip W; Huff Murray W; Hegele Robert A
Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
BMC medical genetics 2007;8():80.
2007: Wittes Janet; Barrett-Connor Elizabeth; Braunwald Eugene; Chesney Margaret; Cohen Harvey Jay; Demets David; Dunn Leo; Dwyer Johanna; Heaney Robert P; Vogel Victor; Walters Leroy; Yusuf Salim
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
Clinical trials (London, England) 2007;4(3):218-34.
2007: Diener Hans-Christoph; Sacco Ralph; Yusuf Salim;
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Cerebrovascular diseases (Basel, Switzerland) 2007;23(5-6):368-80.
2006: McQueen Matthew J; Gerstein Hertzel C; Pogue Janice; Mann Johannes F E; Yusuf Salim
Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;48(6):889-96.
2006: Blankenberg Stefan; Yusuf Salim
The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
Circulation 2006;114(15):1557-60.
2006: Bosch Jackie; Yusuf Salim; Gerstein Hertzel C; Pogue Janice; Sheridan Patrick; Dagenais Gilles; Diaz Rafael; Avezum Alvaro; Lanas Fernando; Probstfield Jeffrey; Fodor George; Holman Rury R
Effect of ramipril on the incidence of diabetes.
The New England journal of medicine 2006;355(15):1551-62.
2006: Anand Sonia S; Razak Fahad; Davis A D; Jacobs Ruby; Vuksan Vlad; Teo Koon; Yusuf Salim
Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects.
International journal of epidemiology 2006;35(5):1239-45.
2006: Goyal Abhinav; Yusuf Salim
The burden of cardiovascular disease in the Indian subcontinent.
The Indian journal of medical research 2006;124(3):235-44.
2006: Gerstein H C; Yusuf S; Bosch J; Pogue J; Sheridan P; Dinccag N; Hanefeld M; Hoogwerf B; Laakso M; Mohan V; Shaw J; Zinman B; Holman R R
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Lancet 2006;368(9541):1096-105.
2006: Dagenais Gilles R; Pogue Janice; Teo Koon K; Lonn Eva M; Yusuf Salim;
Impact of ramipril on the circadian periodicity of acute myocardial infarction.
The American journal of cardiology 2006;98(6):758-60.
2006: Fox Kim; Ferrari Roberto; Yusuf Salim; Borer Jeffrey S
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
European heart journal 2006;27(18):2154-7.
2006: Teo Koon K; Ounpuu Stephanie; Hawken Steven; Pandey M R; Valentin Vicent; Hunt David; Diaz Rafael; Rashed Wafa; Freeman Rosario; Jiang Lixin; Zhang Xiaofei; Yusuf Salim;
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.
Lancet 2006;368(9536):647-58.
2006: Eikelboom John W; Mehta Shamir R; Anand Sonia S; Xie Changchun; Fox Keith A A; Yusuf Salim
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.
Circulation 2006;114(8):774-82.
2006: Dagenais Gilles R; Pogue Janice; Fox Kim; Simoons Marteen L; Yusuf Salim
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.
Lancet 2006;368(9535):581-8.
2006: Devereaux P J; Yang Homer; Guyatt Gordon H; Leslie Kate; Villar Juan Carlos; Monteri Victor M; Choi Peter; Giles Julian W; Yusuf Salim
Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
American heart journal 2006;152(2):223-30.
2006: Ducharme Anique; Swedberg Karl; Pfeffer Marc A; Cohen-Solal Alain; Granger Christopher B; Maggioni Aldo P; Michelson Eric L; McMurray John J V; Olsson Lars; Rouleau Jean L; Young James B; Olofsson Bertil; Puu Margareta; Yusuf Salim;
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;152(1):86-92.
2006: Blankenberg Stefan; McQueen Matthew J; Smieja Marek; Pogue Janice; Balion Cynthia; Lonn Eva; Rupprecht Hans J; Bickel Christoph; Tiret Laurence; Cambien Francois; Gerstein Hertzel; Münzel Thomas; Yusuf Salim;
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2006;114(3):201-8.
2006: Healey Jeffrey S; Toff William D; Lamas Gervasio A; Andersen Henning R; Thorpe Kevin E; Ellenbogen Kenneth A; Lee Kerry L; Skene Allan M; Schron Eleanor B; Skehan J Douglas; Goldman Lee; Roberts Robin S; Camm A John; Yusuf Salim; Connolly Stuart J
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data.
Circulation 2006;114(1):11-7.
2006: Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
Lancet 2006;367(9526):1903-12.
2006: Eisenstein Eric L; Yusuf Salim; Bindal Vishal; Bourassa Martial G; Horney Anne; Collins Joseph F; Mark Daniel B;
What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.
Journal of cardiac failure 2006;12(5):336-42.
2006: McMurray John J V; Andersson Fredrik L; Stewart Simon; Svensson Klas; Solal Alain Cohen; Dietz Rainer; Vanhaecke Johan; van Veldhuisen Dirk J; Ostergren Jan; Granger Christopher B; Yusuf Salim; Pfeffer Marc A; Swedberg Karl
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2006;27(12):1447-58.
2006: Olsson Lars G; Swedberg Karl; Ducharme Anique; Granger Christopher B; Michelson Eric L; McMurray John J V; Puu Margareta; Yusuf Salim; Pfeffer Marc A;
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Journal of the American College of Cardiology 2006;47(10):1997-2004.
2006: Yusuf Salim
Preventing vascular events due to elevated blood pressure.
Circulation 2006;113(18):2166-8.
2006: Ahn Sylvie A; Jong Philip; Yusuf Salim; Bangdiwala Shrikant I; Pouleur Hubert G; Rousseau Michel F
Early versus delayed enalapril in patients with left ventricular systolic dysfunction: impact on morbidity and mortality 15 years after the SOLVD trial.
Journal of the American College of Cardiology 2006;47(9):1904-5.
2006: McMurray John J V; Young James B; Dunlap Mark E; Granger Christopher B; Hainer James; Michelson Eric L; Earle Steven; Olofsson Bertil; Ostergren Jan; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
American heart journal 2006;151(5):985-91.
2006: Ducharme Anique; Swedberg Karl; Pfeffer Marc A; Cohen-Solal Alain; Granger Christopher B; Maggioni Aldo P; Michelson Eric L; McMurray John J V; Olsson Lars; Rouleau Jean L; Young James B; Yusuf Salim
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;151(5):985-91.
2006: Yusuf Salim; Mehta Shamir R; Chrolavicius Susan; Afzal Rizwan; Pogue Janice; Granger Christopher B; Budaj Andrzej; Peters Ron J G; Bassand Jean-Pierre; Wallentin Lars; Joyner Campbell; Fox Keith A A;
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
JAMA : the journal of the American Medical Association 2006;295(13):1519-30.
2006: Yusuf Salim; Mehta Shamir R; Chrolavicius Susan; Afzal Rizwan; Pogue Janice; Granger Christopher B; Budaj Andrzej; Peters Ron J G; Bassand Jean-Pierre; Wallentin Lars; Joyner Campbell; Fox Keith A A
Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
The New England journal of medicine 2006;354(14):1464-76.
2006: Lonn Eva; Yusuf Salim; Arnold Malcolm J; Sheridan Patrick; Pogue Janice; Micks Mary; McQueen Matthew J; Probstfield Jeffrey; Fodor George; Held Claes; Genest Jacques;
Homocysteine lowering with folic acid and B vitamins in vascular disease.
The New England journal of medicine 2006;354(15):1567-77.
2006: O'Meara Eileen; Clayton Tim; McEntegart Margaret B; McMurray John J V; Lang Chim C; Roger Simon D; Young James B; Solomon Scott D; Granger Christopher B; Ostergren Jan; Olofsson Bertil; Michelson Eric L; Pocock Stuart; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
Circulation 2006;113(7):986-94.
2006: Hillege Hans L; Nitsch Dorothea; Pfeffer Marc A; Swedberg Karl; McMurray John J V; Yusuf Salim; Granger Christopher B; Michelson Eric L; Ostergren Jan; Cornel Jan Hein; de Zeeuw Dick; Pocock Stuart; van Veldhuisen Dirk J;
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Lonn E; Held C; Arnold J M O; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
The Canadian journal of cardiology 2006;22(1):47-53.
2006: Mahoney Elizabeth M; Mehta Shamir; Yuan Yong; Jackson Joseph; Chen Roland; Gabriel Sylvie; Lamy Andre; Culler Steven; Caro Jaime; Yusuf Salim; Weintraub William S;
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
American heart journal 2006;151(1):219-27.
2006: Pocock Stuart J; Wang Duolao; Pfeffer Marc A; Yusuf Salim; McMurray John J V; Swedberg Karl B; Ostergren Jan; Michelson Eric L; Pieper Karen S; Granger Christopher B
Predictors of mortality and morbidity in patients with chronic heart failure.
European heart journal 2006;27(1):65-75.
2006: Abdulla Jawdat; Pogue Janice; Abildstrøm Steen Z; Køber Lars; Christensen Erik; Pfeffer Marc A; Yusuf Salim; Torp-Pedersen Christian
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(1):90-6.
2006: Yusuf Salim; Bosch Jackie
Independent design and conduct of clinical trials.
Clinical trials (London, England) 2006;3(6):503-7.
2005: Mills Edward J; Robinson Janet; Attaran Amir; Clarke Mike; Singh Sonal; Upshur Ross E; Herrmann Kenneth J; Yusuf Salim
Sharing evidence on humanitarian relief.
BMJ (Clinical research ed.) 2005;331(7531):1485-6.
2005: Eikelboom John W; Quinlan Daniel J; Mehta Shamir R; Turpie Alexander G; Menown Ian B; Yusuf Salim
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Circulation 2005;112(25):3855-67.
2005: Granger Bradi B; Swedberg Karl; Ekman Inger; Granger Christopher B; Olofsson Bertil; McMurray John J V; Yusuf Salim; Michelson Eric L; Pfeffer Marc A;
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.
Lancet 2005;366(9502):2005-11.
2005: Lewis Basil S; Mehta Shamir R; Fox Keith A A; Halon David A; Zhao Feng; Peters Ron J G; Keltai Matyas; Budaj Andrzej; Yusuf Salim;
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
American heart journal 2005;150(6):1177-84.
2005: Mehta Shamir R; Yusuf Salim; Granger Christopher B; Wallentin Lars; Peters Ron J G; Bassand Jean-Pierre; Budaj Andrzej; Joyner Campbell; Chrolavicius Susan; Fox Keith A A
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2005;150(6):1107.
2005: Steyn Krisela; Sliwa Karen; Hawken Steven; Commerford Patrick; Onen Churchill; Damasceno Albertino; Ounpuu Stephanie; Yusuf Salim;
Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study.
Circulation 2005;112(23):3554-61.
2005: Solomon Scott D; Anavekar Nagesh; Skali Hicham; McMurray John J V; Swedberg Karl; Yusuf Salim; Granger Christopher B; Michelson Eric L; Wang Duolao; Pocock Stuart; Pfeffer Marc A;
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Circulation 2005;112(24):3738-44.
2005: Roccaforte Rosa; Demers Catherine; Baldassarre Fulvia; Teo Koon K; Yusuf Salim
Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(7):1133-44.
2005: Mendis Shanthi; Abegunde Dele; Yusuf Salim; Ebrahim Shah; Shaper Gerry; Ghannem Hassen; Shengelia Bakuti
WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).
Bulletin of the World Health Organization 2005;83(11):820-9.
2005: Mathew James; Wittes Janet; McSherry Frances; Williford William; Garg Rekha; Probstfield Jeffrey; Yusuf Salim;
Racial differences in outcome and treatment effect in congestive heart failure.
American heart journal 2005;150(5):968-76.
2005: Anand Sonia S; Xie Chang Chun; Mehta Shamir; Franzosi Maria Grazia; Joyner Campbell; Chrolavicius Susan; Fox Keith A A; Yusuf Salim;
Differences in the management and prognosis of women and men who suffer from acute coronary syndromes.
Journal of the American College of Cardiology 2005;46(10):1845-51.
2005: Yusuf Salim; Hawken Steven; Ounpuu Stephanie; Bautista Leonelo; Franzosi Maria Grazia; Commerford Patrick; Lang Chim C; Rumboldt Zvonko; Onen Churchill L; Lisheng Liu; Tanomsup Supachai; Wangai Paul; Razak Fahad; Sharma Arya M; Anand Sonia S;
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.
Lancet 2005;366(9497):1640-9.
2005: Sinnaeve Peter R; Simes John; Yusuf Salim; Garg Jyotsna; Mehta Shamir; Eikelboom John; Bittl John A; Serruys Patrick; Topol Eric J; Granger Christopher B
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention.
European heart journal 2005;26(22):2396-403.
2005: Demers Catherine; McMurray John J V; Swedberg Karl; Pfeffer Marc A; Granger Christopher B; Olofsson Bertil; McKelvie Robert S; Ostergren Jan; Michelson Eric L; Johansson Peter A; Wang Duolao; Yusuf Salim;
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
JAMA : the journal of the American Medical Association 2005;294(14):1794-8.
2005: Devereaux P J; Goldman Lee; Yusuf Salim; Gilbert Ken; Leslie Kate; Guyatt Gordon H
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;173(7):779-88.
2005: Yusuf Salim
Intensive insulin-glucose infusion regimens with long-term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI.
ACP journal club 2005;143(2):43.
2005: Yan Raymond T; White Michel; Yan Andrew T; Yusuf Salim; Rouleau Jean L; Maggioni Aldo P; Hall Christian; Latini Roberto; Afzal Rizwan; Floras John; Masson Serge; McKelvie Robert S;
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
The American journal of cardiology 2005;96(5):698-704.
2005: Gerstein H C; Pogue J; Mann J F E; Lonn E; Dagenais G R; McQueen M; Yusuf S;
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
Diabetologia 2005;48(9):1749-55.
2005: Bosch Jackie; Lonn Eva; Pogue Janice; Arnold J Malcolm O; Dagenais Gilles R; Yusuf Salim;
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
Circulation 2005;112(9):1339-46.
2005: Devereaux P J; Beattie W Scott; Choi Peter T-L; Badner Neal H; Guyatt Gordon H; Villar Juan C; Cinà Claudio S; Leslie Kate; Jacka Michael J; Montori Victor M; Bhandari Mohit; Avezum Alvaro; Cavalcanti Alexandre B; Giles Julian W; Schricker Thomas; Yang Homer; Jakobsen Carl-Johan; Yusuf Salim
How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials.
BMJ (Clinical research ed.) 2005;331(7512):313-21.
2005: Natarajan Madhu K; Gafni Amiram; Yusuf Salim
Determining optimal population rates of cardiac catheterization: a phantom alternative?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;173(1):49-52.
2005: Yusuf Salim; Ostergren Jan B; Gerstein Hertzel C; Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Olofsson Bertil; Probstfield Jeffrey; McMurray John V;
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.
Circulation 2005;112(1):48-53.
2005: Mehta Shamir R; Cannon Christopher P; Fox Keith A A; Wallentin Lars; Boden William E; Spacek Rudolf; Widimsky Petr; McCullough Peter A; Hunt David; Braunwald Eugene; Yusuf Salim
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2005;293(23):2908-17.
2005: Healey Jeff S; Baranchuk Adrian; Crystal Eugene; Morillo Carlos A; Garfinkle Michael; Yusuf Salim; Connolly Stuart J
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
Journal of the American College of Cardiology 2005;45(11):1832-9.
2005: O'Meara Eileen; Lewis Eldrin; Granger Chris; Dunlap Mark E; McKelvie Robert S; Probstfield Jeffrey L; Young James B; Michelson Eric L; Ostergren Jan; Carlsson Jonas; Olofsson Bertil; McMurray John; Yusuf Salim; Swedberg Karl; Pfeffer Marc A
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(4):650-6.
2005: Razak F; Anand S; Vuksan V; Davis B; Jacobs R; Teo K K; Yusuf S;
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study.
International journal of obesity (2005) 2005;29(6):656-67.
2005: Prabhakaran Dorairaj; Yusuf Salim; Mehta Shamir; Pogue Janice; Avezum Alvaro; Budaj Andrzej; Cerumzynski Leszek; Flather Marcus; Fox Keith; Hunt David; Lisheng Liu; Keltai Matyas; Parkhomenko Alexander; Pais Prem; Reddy Srinath; Ruda Mikhail; Hiquing Tan; Jun Zhu
Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.
Indian heart journal 2005;57(3):217-25.
2005: Merchant Anwar T; Anand Sonia S; Vuksan Vlad; Jacobs Ruby; Davis Bonnie; Teo Koon; Yusuf Salim;
Protein intake is inversely associated with abdominal obesity in a multi-ethnic population.
The Journal of nutrition 2005;135(5):1196-201.
2005: Merchant Anwar T; Anand Sonia S; Yusuf Salim
Commentary: insights from cross-population studies: Rose revisited.
International journal of epidemiology 2005;34(2):244-6.
2005: Mehta Shamir R; Steg Philippe Gabriel; Granger Christopher B; Bassand Jean-Pierre; Faxon David P; Weitz Jeffrey I; Afzal Rizwan; Rush Bonnie; Peters Ron J G; Natarajan Madhu K; Velianou James L; Goodhart David M; Labinaz Marino; Tanguay Jean-Francois; Fox Keith A A; Yusuf Salim;
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
Circulation 2005;111(11):1390-7.
2005: Lonn Eva; Bosch Jackie; Yusuf Salim; Sheridan Patrick; Pogue Janice; Arnold J Malcolm O; Ross Catherine; Arnold Andrew; Sleight Peter; Probstfield Jeffrey; Dagenais Gilles R;
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(11):1338-47.
2005: Weintraub William S; Mahoney Elizabeth M; Lamy Andre; Culler Steven; Yuan Yong; Caro Jaime; Gabriel Sylvie; Yusuf Salim;
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
Journal of the American College of Cardiology 2005;45(6):838-45.
2005: Yusuf Salim; Pogue Janice
ACE inhibition in stable coronary artery disease.
The New England journal of medicine 2005;352(9):937-9; author reply 937-9.
2005: Dagenais Gilles R; Yi Qilong; Lonn Eva; Sleight Peter; Ostergren Jan; Yusuf Salim;
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2005;12(1):75-81.
2005: Ishani Areef; Weinhandl Eric; Zhao Zihong; Gilbertson David T; Collins Allan J; Yusuf Salim; Herzog Charles A
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
Journal of the American College of Cardiology 2005;45(3):391-9.
2005: Mehta Shamir R; Eikelboom John W; Demers Catherine; Maggioni Aldo P; Commerford Patrick J; Yusuf Salim
Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.
Canadian journal of physiology and pharmacology 2005;83(1):98-103.
2005: Mehta Shamir R; Yusuf Salim; Díaz Rafael; Zhu Jun; Pais Prem; Xavier Denis; Paolasso Ernesto; Ahmed Rashid; Xie Changchun; Kazmi Khawar; Tai Javed; Orlandini Andrés; Pogue Janice; Liu Lisheng;
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(4):437-46.
2005: Yusuf Salim; Mehta Shamir R; Xie Changchun; Ahmed Rashid J; Xavier Denis; Pais Prem; Zhu Jun; Liu Lisheng;
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
JAMA : the journal of the American Medical Association 2005;293(4):427-35.
2005: Dagenais Gilles R; Yi Qilong; Mann Johannes F E; Bosch Jackie; Pogue Janice; Yusuf Salim
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.
American heart journal 2005;149(1):54-60.
2005: Devereaux P J; Bhandari Mohit; Clarke Mike; Montori Victor M; Cook Deborah J; Yusuf Salim; Sackett David L; Cinà Claudio S; Walter S D; Haynes Brian; Schünemann Holger J; Norman Geoffrey R; Guyatt Gordon H
Need for expertise based randomised controlled trials.
BMJ (Clinical research ed.) 2005;330(7482):88.
2005: Merchant Anwar T; Dehghan Mahshid; Chifamba Jephat; Terera Getrude; Yusuf Salim
Nutrient estimation from an FFQ developed for a Black Zimbabwean population.
Nutrition journal 2005;4():37.
2005: McQueen M J; Lonn E; Gerstein H C; Bosch J; Yusuf S
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2005;240():143-56.
2005: Dehghan Mahshid; Al Hamad Nawal; Yusufali AfzalHussein; Nusrath Fathimunissa; Yusuf Salim; Merchant Anwar T
Development of a semi-quantitative food frequency questionnaire for use in United Arab Emirates and Kuwait based on local foods.
Nutrition journal 2005;4():18.
2004: Yusuf Salim; Mehta Shamir R; Díaz Rafael; Paolasso Ernesto; Pais Prem; Xavier Denis; Xie Changchun; Ahmed Rashid J; Khazmi Khawar; Zhu Jun; Liu Lisheng;
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.
American heart journal 2004;148(6):1068-78.
2004: Lamy Andre; Jönsson Bengt; Weintraub William S; Zhao Feng; Chrolavicius Susan; Bakhai Ameet; Culler Steven; Gafni Amiram; Lindgren Peter; Mahoney Elizabeth; Yusuf Salim;
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2004;11(6):460-5.
2004: O'Meara Eileen; Solomon Scott; McMurray John; Pfeffer Marc; Yusuf Salim; Michelson Eric; Granger Chris; Olofsson Bertil; Young James B; Swedberg Karl
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2004;25(21):1920-6.
2004: Young James B; Dunlap Mark E; Pfeffer Marc A; Probstfield Jeffrey L; Cohen-Solal Alain; Dietz Rainer; Granger Christopher B; Hradec Jaromir; Kuch Jerzy; McKelvie Robert S; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Held Peter; Solomon Scott D; Yusuf Salim; Swedberg Karl;
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Circulation 2004;110(17):2618-26.
2004: Yusuf Salim
Randomized clinical trials: slow death by a thousand unnecessary policies?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;171(8):889-92; discussion 892-3.
2004: Solomon Scott D; Wang Duolao; Finn Peter; Skali Hicham; Zornoff Leonardo; McMurray John J V; Swedberg Karl; Yusuf Salim; Granger Christopher B; Michelson Eric L; Pocock Stuart; Pfeffer Marc A
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2004;110(15):2180-3.
2004: Kelemen Linda E; Anand Sonia S; Hegele Robert A; Stampfer Meir J; Rosner Bernard; Willett Walter C; Montague Patricia A; Lonn Eva; Vuksan Vladimir; Teo Koon K; Devanesen Sudarshan; Yusuf Salim
Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.
Atherosclerosis 2004;176(2):361-70.
2004: Rosengren Annika; Hawken Steven; Ounpuu Stephanie; Sliwa Karen; Zubaid Mohammad; Almahmeed Wael A; Blackett Kathleen Ngu; Sitthi-amorn Chitr; Sato Hiroshi; Yusuf Salim;
Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.
Lancet 2004;364(9438):953-62.
2004: Yusuf Salim; Hawken Steven; Ounpuu Stephanie; Dans Tony; Avezum Alvaro; Lanas Fernando; McQueen Matthew; Budaj Andrzej; Pais Prem; Varigos John; Lisheng Liu;
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
Lancet 2004;364(9438):937-52.
2004: Teo Koon K; Mitchell L Brent; Pogue Janice; Bosch Jackie; Dagenais Gilles; Yusuf Salim;
Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Circulation 2004;110(11):1413-7.
2004: Gerstein H C; Yusuf S; Holman R; Bosch J; Pogue J;
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
Diabetologia 2004;47(9):1519-27.
2004: Fox Keith A A; Mehta Shamir R; Peters Ron; Zhao Feng; Lakkis Nasser; Gersh Bernard J; Yusuf Salim;
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Circulation 2004;110(10):1202-8.
2004: Yusuf Salim;
Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: the story of GISSI.
American heart journal 2004;148(2):193-5.
2004: Devereaux P J; Yusuf Salim; Yang Homer; Choi Peter T-L; Guyatt Gordon H
Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;171(3):245-7.
2004: Anand Sonia S; Razak Fahad; Yi Qilong; Davis Bonnie; Jacobs Ruby; Vuksan Vlad; Lonn Eva; Teo Koon; McQueen Matthew; Yusuf Salim
C-reactive protein as a screening test for cardiovascular risk in a multiethnic population.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(8):1509-15.
2004: Neufeld Vic; Yusuf Salim
The McMaster-Lancet health and peace conferences.
Lancet 2004;364(9431):311-2.
2004: Teo Koon; Yusuf Salim; Sleight Peter; Anderson Craig; Mookadam Farouk; Ramos Barbara; Hilbrich Lutz; Pogue Janice; Schumacher Helmut;
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
American heart journal 2004;148(1):52-61.
2004: Yusuf Salim; Vaz Mario; Pais Prem
Tackling the challenge of cardiovascular disease burden in developing countries.
American heart journal 2004;148(1):1-4.
2004: Smith Sidney C; Jackson Rod; Pearson Thomas A; Fuster Valentin; Yusuf Salim; Faergeman Ole; Wood David A; Alderman Michael; Horgan John; Home Philip; Hunn Marilyn; Grundy Scott M
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
Circulation 2004;109(25):3112-21.
2004: Lonn Eva; Shaikholeslami Roya; Yi Qilong; Bosch Jackie; Sullivan Brian; Tanser Paul; Magi Alison; Yusuf Salim
Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
Journal of the American College of Cardiology 2004;43(12):2200-6.
2004: Theal Michael; Sleik Khalid; Anand Sonia; Yi Qilong; Yusuf Salim; Lonn Eva
Prevalence of mitral valve prolapse in ethnic groups.
The Canadian journal of cardiology 2004;20(5):511-5.
2004: Mann Johannes F E; Lonn Eva M; Yi Qilong; Gerstein Hertzel C; Hoogwerf Byron J; Pogue Janice; Bosch Jackie; Dagenais Gilles R; Yusuf Salim;
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
Kidney international 2004;65(4):1375-80.
2004: Brophy James M; Dagenais Gilles R; McSherry Frances; Williford William; Yusuf Salim
A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction.
The American journal of medicine 2004;116(5):300-4.
2004: Kerr Charles R; Connolly Stuart J; Abdollah Hoshiar; Roberts Robin S; Gent Michael; Yusuf Salim; Gillis Anne M; Tang Anthony S L; Talajic Mario; Klein George J; Newman David M
Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up.
Circulation 2004;109(3):357-62.
2004: Crystal E; Garfinkle M S; Connolly S S; Ginger T T; Sleik K; Yusuf S S
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Cochrane database of systematic reviews (Online) 2004;(4):CD003611.
2003: Lonn Eva; Mathew James; Pogue Janice; Johnstone David; Danisa Kola; Bosch Jackie; Baird Michael; Dagenais Gilles; Sleight Peter; Yusuf Salim;
Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(6):420-8.
2003: Egan Debra; Geller Nancy; Yusuf Salim; Garg Rekha; Collins Joseph F; Mathew James; Philbin Edward;
Lessons learned from the DIG trial.
Controlled clinical trials 2003;24(6 Suppl):316S-326S.
2003: Fye Carol L; Gagne William H; Raisch Dennis W; Jones Mark S; Sather Mike R; Buchanan Sandra L; Chacon Frances R; Garg Rekha; Yusuf Salim; Williford William O;
The role of the pharmacy coordinating center in the DIG trial.
Controlled clinical trials 2003;24(6 Suppl):289S-297S.
2003: Williford William O; Collins Joseph F; Horney Anne; Kirk Gail; McSherry Frances; Spence Elizabeth; Stinnett Susan; Howell Cindy L; Garg Rekha; Egan Debra; Yusuf Salim;
The role of the data coordinating center in the DIG trial.
Controlled clinical trials 2003;24(6 Suppl):277S-288S.
2003: Collins Joseph F; Egan Debra; Yusuf Salim; Garg Rekha; Williford William O; Geller Nancy;
Overview of the DIG trial.
Controlled clinical trials 2003;24(6 Suppl):269S-276S.
2003: Dagenais Gilles R; Auger Pierre; Bogaty Peter; Gerstein Hertzel; Lonn Eva; Yi Qilong; Yusuf Salim;
Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity.
The Canadian journal of cardiology 2003;19(12):1387-91.
2003: Rihal Charanjit S; Raco Dominic L; Gersh Bernard J; Yusuf Salim
Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.
Circulation 2003;108(20):2439-45.
2003: Mann Johannes F E; Gerstein Hertzel C; Yi Qi-Long; Franke Jörg; Lonn Eva M; Hoogwerf Byron J; Rashkow Andrew; Yusuf Salim;
Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(5):936-42.
2003: McKelvie Robert S; Rouleau Jean-Lucien; White Michel; Afzal Rizwan; Young James B; Maggioni Aldo P; Held Peter; Yusuf Salim
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
European heart journal 2003;24(19):1727-34.
2003: Peters Ron J G; Mehta Shamir R; Fox Keith A A; Zhao Feng; Lewis Basil S; Kopecky Steven L; Diaz Rafael; Commerford Patrick J; Valentin Vicent; Yusuf Salim;
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Circulation 2003;108(14):1682-7.
2003: Yusuf Salim; Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Held Peter; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan;
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet 2003;362(9386):777-81.
2003: Granger Christopher B; McMurray John J V; Yusuf Salim; Held Peter; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Pfeffer Marc A; Swedberg Karl;
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet 2003;362(9386):772-6.
2003: McMurray John J V; Ostergren Jan; Swedberg Karl; Granger Christopher B; Held Peter; Michelson Eric L; Olofsson Bertil; Yusuf Salim; Pfeffer Marc A;
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Lancet 2003;362(9386):767-71.
2003: Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Held Peter; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Yusuf Salim; Pocock Stuart;
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet 2003;362(9386):759-66.
2003: Kelemen Linda E; Anand Sonia S; Vuksan Vladimir; Yi Qilong; Teo Koon K; Devanesen Sudarshan; Yusuf Salim;
Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese, and Europeans in North America.
Journal of the American Dietetic Association 2003;103(9):1178-84.
2003: Sleight Peter; Yusuf Salim
New evidence on the importance of the renin-angiotensin system in the treatment of higher-risk patients with hypertension.
Journal of hypertension 2003;21(9):1599-608.
2003: Hackam Daniel G; Anand Sonia S; Yusuf Salim
Oral anticoagulant therapy in patients with coronary artery disease.
Seminars in vascular medicine 2003;3(3):323-32.
2003: Yusuf Salim; Ounpuu Stephanie
Tackling the growing global burden of atherosclerotic cardiovascular diseases.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(4):236-9.
2003: Devereaux P J; McKee Michael D; Yusuf Salim
Methodologic issues in randomized controlled trials of surgical interventions.
Clinical orthopaedics and related research 2003;(413):25-32.
2003: Anand Sonia S; Yi Qilong; Gerstein Hertzel; Lonn Eva; Jacobs Ruby; Vuksan Vlad; Teo Koon; Davis Bonnie; Montague Patty; Yusuf Salim;
Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.
Circulation 2003;108(4):420-5.
2003: Natarajan Madhu K; Yusuf Salim
Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;169(1):32-5.
2003: Yusuf Salim; Dagenais Gilles
More than just hype.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(13):1646; author reply 1647-8.
2003: McMurray J; Ostergren J; Pfeffer M; Swedberg K; Granger C; Yusuf S; Held P; Michelson E; Olofsson B;
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(3):261-70.
2003: Anand Sonia S; Yusuf Salim; Pogue Janice; Ginsberg Jeffrey S; Hirsh Jack;
Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
Circulation 2003;107(23):2884-8.
2003: Jong Philip; Yusuf Salim; Rousseau Michel F; Ahn Sylvie A; Bangdiwala Shrikant I
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
Lancet 2003;361(9372):1843-8.
2003: Anker Stefan D; Negassa Abdissa; Coats Andrew J S; Afzal Rizwan; Poole-Wilson Philip A; Cohn Jay N; Yusuf Salim
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Lancet 2003;361(9363):1077-83.
2003: Arnold J Malcolm O; Yusuf Salim; Young James; Mathew James; Johnstone David; Avezum Alvaro; Lonn Eva; Pogue Janice; Bosch Jackie;
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2003;107(9):1284-90.
2003: Mann Johannes F E; Gerstein Hertzel C; Yi Qi-Long; Lonn Eva M; Hoogwerf Byron J; Rashkow Andrew; Yusuf Salim
Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.
Journal of the American Society of Nephrology : JASN 2003;14(3):641-7.
2003: Mehta Shamir R; Yusuf Salim
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Journal of the American College of Cardiology 2003;41(4 Suppl S):79S-88S.
2003: Eikelboom John; White Harvey; Yusuf Salim
The evolving role of direct thrombin inhibitors in acute coronary syndromes.
Journal of the American College of Cardiology 2003;41(4 Suppl S):70S-78S.
2003: Anand Sonia S; Yusuf Salim
Oral anticoagulants in patients with coronary artery disease.
Journal of the American College of Cardiology 2003;41(4 Suppl S):62S-69S.
2003: Yusuf Salim; Mehta Shamir R; Zhao Feng; Gersh Bernard J; Commerford Patrick J; Blumenthal Mel; Budaj Andrzej; Wittlinger Thomas; Fox Keith A A;
Early and late effects of clopidogrel in patients with acute coronary syndromes.
Circulation 2003;107(7):966-72.
2003: Lamy Andre; Yusuf Salim; Pogue Janice; Gafni Amiram;
Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study.
Circulation 2003;107(7):960-5.
2003: Anand Sonia S; Razak Fahad; Vuksan Vlad; Gerstein Hertzel C; Malmberg Klas; Yi Qilong; Teo Koon K; Yusuf Salim
Diagnostic strategies to detect glucose intolerance in a multiethnic population.
Diabetes care 2003;26(2):290-6.
2003: Smieja Marek; Gnarpe Judy; Lonn Eva; Gnarpe Håkan; Olsson Gunnar; Yi Qilong; Dzavik Vladimir; McQueen Matthew; Yusuf Salim;
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2003;107(2):251-7.
2003: Yusuf Salim; Bosch Jackie; Sleight Peter
Preventing stroke with ramipril--authors' reply.
BMJ (Clinical research ed.) 2003;326(7379):52.
2003: Gerstein Hertzel C; Anand Sonia; Yi Qi Long; Vuksan Vladimir; Lonn Eva; Teo Koon; Malmberg Klas; McQueen Matthew; Yusuf Salim;
The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.
Diabetes care 2003;26(1):144-9.
2002: Parker Andrea B; Yusuf Salim; Naylor C David
The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
American heart journal 2002;144(6):941-7.
2002: Miller Todd D; Piegas Leopoldo S; Gibbons Raymond J; Yi Cheelong; Yusuf Salim
Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction.
The American journal of cardiology 2002;90(12):1370-4.
2002: Yusuf Salim; Pitt Bertram
A lifetime of prevention: the case of heart failure.
Circulation 2002;106(24):2997-8.
2002: Natarajan Madhu K; Mehta Shamir R; Holder Douglas H; Goodhart David R; Gafni Amiram; Shilton Donald; Afzal Rizwan; Teo Koon; Yusuf Salim
The risks of waiting for cardiac catheterization: a prospective study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(11):1233-40.
2002: Armstrong Paul; Cashman Neil R; Cook Deborah J; Feeny David H; Ghali William A; de Gruijl Frank R; Hall Judith G; Herbert Carol P; Iscoe Neill; Jadad Alejandro R; Kassirer Jerome P; McAlister Finlay A; McGeer Allison J; MacMillan Harriet L; Moher David; Phillips Susan; Redelmeier Donald A; Schechter Martin T; Veldhuyzen van Zanten Sander J O; Yusuf Salim
A letter from CMAJ's editorial board to the CMA.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(11):1230; author reply 1230-1.
2002: Veres Amarilla; Füst George; Smieja Marek; McQueen Matthew; Horváth Anna; Yi Qilong; Bíró Adrienn; Pogue Janice; Romics László; Karádi István; Singh Mahavir; Gnarpe Judy; Prohászka Zoltán; Yusuf Salim;
Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.
Circulation 2002;106(22):2775-80.
2002: Lonn Eva; Yusuf Salim; Hoogwerf Byrcon; Pogue Janice; Yi Qilong; Zinman Bernard; Bosch Jackie; Dagenais Gilles; Mann Johannes F E; Gerstein Hertzel C;
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes care 2002;25(11):1919-27.
2002: Teo Koon K; Yusuf Salim; Pfeffer Marc; Torp-Pedersen Christian; Kober Lars; Hall Alistair; Pogue Janice; Latini Roberto; Collins Rory;
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
Lancet 2002;360(9339):1037-43.
2002: Yusuf Salim
Clinical research and trials in developing countries.
Statistics in medicine 2002;21(19):2859-67.
2002: Budaj Andrzej; Yusuf Salim; Mehta Shamir R; Fox Keith A A; Tognoni Gianni; Zhao Feng; Chrolavicius Susan; Hunt David; Keltai Matyas; Franzosi Maria Grazia;
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups.
Circulation 2002;106(13):1622-6.
2002: Sleight Peter; Yusuf Salim
Who is fooling us?
Lancet 2002;360(9336):873-4.
2002: Lonn Eva; Roccaforte Rosa; Yi Qilong; Dagenais Gilles; Sleight Peter; Bosch Jackie; Suhan Pamela; Micks Mary; Probstfield Jeffrey; Bernstein Victoria; Yusuf Salim;
Effect of long-term therapy with ramipril in high-risk women.
Journal of the American College of Cardiology 2002;40(4):693-702.
2002: Yusuf Salim; Anand Sonia
Hormone replacement therapy: a time for pause.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(4):357-9.
2002: Yusuf Salim
Two decades of progress in preventing vascular disease.
Lancet 2002;360(9326):2-3.
2002: McKelvie Robert S; Teo Koon K; Roberts Robin; McCartney Neil; Humen Dennis; Montague Terence; Hendrican Katie; Yusuf Salim
Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT).
American heart journal 2002;144(1):23-30.
2002: Crystal Eugene; Connolly Stuart J; Sleik Khaled; Ginger Tracy J; Yusuf Salim
Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis.
Circulation 2002;106(1):75-80.
2002: Eikelboom John W; Hirsh Jack; Weitz Jeffrey I; Johnston Marilyn; Yi Qilong; Yusuf Salim
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Circulation 2002;105(14):1650-5.
2002: Gupta Milan; Doobay Anand V; Singh Narendra; Anand Sonia S; Raja Faisal; Mawji Fazeelat; Kho Julian; Karavetian Alice; Yi Qilong; Yusuf Salim
Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(6):717-22.
2002: Bosch Jackie; Yusuf Salim; Pogue Janice; Sleight Peter; Lonn Eva; Rangoonwala Badrudin; Davies Richard; Ostergren Jan; Probstfield Jeff;
Use of ramipril in preventing stroke: double blind randomised trial.
BMJ (Clinical research ed.) 2002;324(7339):699-702.
2002: Yusuf Salim
From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.
The American journal of cardiology 2002;89(2A):18A-25A; discussion 25A-26A.
2002: Mehta S R; Eikelboom J W; Rupprecht H-J; Lewis B S; Natarajan M K; Yi C; Pogue J; Yusuf S
Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
European heart journal 2002;23(2):117-23.
2002: Yusuf Salim; Negassa Abdissa
Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes?
American heart journal 2002;143(1):22-8.
2002: Burns Robert J; Gibbons Raymond J; Yi Qilong; Roberts Robin S; Miller Todd D; Schaer Gary L; Anderson Jeffrey L; Yusuf Salim;
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis.
Journal of the American College of Cardiology 2002;39(1):30-6.
2002: Mann Johannes F E; Gerstein Hertzel C; Pogue Janice; Lonn Eva; Yusuf Salim
Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2002;2(3):157-62.
2002: Yusuf Salim; Ounpuu Stephanie; Anand Sonia
The global epidemic of atherosclerotic cardiovascular disease.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2002;11 Suppl 2():3-8.
2002: Villar J C; Marin-Neto J A; Ebrahim S; Yusuf S
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.
Cochrane database of systematic reviews (Online) 2002;(1):CD003463.
2001: Liu P; Arnold M; Belenkie I; Howlett J; Huckell V; Ignazewski A; LeBlanc M H; McKelvie R; Niznick J; Parker J D; Rao V; Ross H; Roy D; Smith S; Sussex B; Teo K; Tsuyuki R; White M; Beanlands D; Bernstein V; Davies R; Issac D; Johnstone D; Lee H; Moe G; Newton G; Pflugfelder P; Roth S; Rouleau J; Yusuf S;
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
The Canadian journal of cardiology 2001;17 Suppl E():5E-25E.
2001: Yusuf S; Reddy S; Ounpuu S; Anand S
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.
Circulation 2001;104(23):2855-64.
2001: Yusuf S; Reddy S; Ounpuu S; Anand S
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.
Circulation 2001;104(22):2746-53.
2001: Anand S S; Yusuf S; Jacobs R; Davis A D; Yi Q; Gerstein H; Montague P A; Lonn E
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).
Lancet 2001;358(9288):1147-53.
2001: Yusuf S; Gerstein H; Hoogwerf B; Pogue J; Bosch J; Wolffenbuttel B H; Zinman B;
Ramipril and the development of diabetes.
JAMA : the journal of the American Medical Association 2001;286(15):1882-5.
2001: Mathew J; Sleight P; Lonn E; Johnstone D; Pogue J; Yi Q; Bosch J; Sussex B; Probstfield J; Yusuf S;
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.
Circulation 2001;104(14):1615-21.
2001: Demers C; McKelvie R S; Negassa A; Yusuf S;
Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure.
American heart journal 2001;142(4):698-703.
2001: Rich M W; McSherry F; Williford W O; Yusuf S;
Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study.
Journal of the American College of Cardiology 2001;38(3):806-13.
2001: Mehta S R; Yusuf S; Peters R J; Bertrand M E; Lewis B S; Natarajan M K; Malmberg K; Rupprecht H; Zhao F; Chrolavicius S; Copland I; Fox K A;
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Lancet 2001;358(9281):527-33.
2001: Yusuf S; Zhao F; Mehta S R; Chrolavicius S; Tognoni G; Fox K K;
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
The New England journal of medicine 2001;345(7):494-502.
2001: Gerstein H C; Mann J F; Yi Q; Zinman B; Dinneen S F; Hoogwerf B; Hallé J P; Young J; Rashkow A; Joyce C; Nawaz S; Yusuf S;
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
JAMA : the journal of the American Medical Association 2001;286(4):421-6.
2001: Cronin L; Mehta S R; Zhao F; Pogue J; Budaj A; Hunt D; Yusuf S
Stroke in relation to cardiac procedures in patients with non-ST-elevation acute coronary syndrome: a study involving >18 000 patients.
Circulation 2001;104(3):269-74.
2001: Tang A S; Roberts R S; Kerr C; Gillis A M; Green M S; Talajic M; Yusuf S; Abdollah H; Gent M; Connolly S J
Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes.
Circulation 2001;103(25):3081-5.
2001: Ounpuu S; Negassa A; Yusuf S
INTER-HEART: A global study of risk factors for acute myocardial infarction.
American heart journal 2001;141(5):711-21.
2001: Mann J F; Gerstein H C; Pogue J; Bosch J; Yusuf S
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
Annals of internal medicine 2001;134(8):629-36.
2001: Lonn E; Yusuf S; Dzavik V; Doris C; Yi Q; Smith S; Moore-Cox A; Bosch J; Riley W; Teo K;
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
Circulation 2001;103(7):919-25.
2001: Eikelboom J W; Anand S S; Mehta S R; Weitz J I; Yi C; Yusuf S
Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study.
Circulation 2001;103(5):643-50.
2001: Eikelboom J W; Mehta S R; Pogue J; Yusuf S
Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy.
JAMA : the journal of the American Medical Association 2001;285(4):444-50.
2001: Mehta S R; Eikelboom J W; Natarajan M K; Diaz R; Yi C; Gibbons R J; Yusuf S
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
Journal of the American College of Cardiology 2001;37(1):37-43.
2000: Anand S S; Yusuf S; Vuksan V; Devanesen S; Teo K K; Montague P A; Kelemen L; Yi C; Lonn E; Gerstein H; Hegele R A
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).
Indian heart journal 2000;52(7 Suppl):S35-43.
2000: Granger C B; Keavney B; Francomano C; Olsson G; Yusuf S
Recommendations for national and local regulatory authorities concerning research in genetic markers of disease.
American heart journal 2000;140(4):S3-5.
2000: Hendrican M C; McKelvie R S; Smith T; McCartney N; Pogue J; Teo K K; Yusuf S
Functional capacity in patients with congestive heart failure.
Journal of cardiac failure 2000;6(3):214-9.
2000: Flather M D; Weitz J I; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner C D; Morris A L; Lai C; Théroux P; Marquis J F; Chan Y K; Venkatesh G; Jessel A
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
European heart journal 2000;21(17):1473-81.
2000: Mehta S R; Eikelboom J W; Yusuf S
Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis.
Lancet 2000;356(9228):449-54.
2000: Suskin N; McKelvie R S; Burns R J; Latini R; Pericak D; Probstfield J; Rouleau J L; Sigouin C; Solymoss C B; Tsuyuki R; White M; Yusuf S
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
European heart journal 2000;21(16):1368-75.
2000: Chareonthaitawee P; Gibbons R J; Roberts R S; Christian T F; Burns R; Yusuf S
The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).
Heart (British Cardiac Society) 2000;84(2):142-8.
2000: Anand S S; Yusuf S; Vuksan V; Devanesen S; Teo K K; Montague P A; Kelemen L; Yi C; Lonn E; Gerstein H; Hegele R A; McQueen M
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Lancet 2000;356(9226):279-84.
2000: Eikelboom J W; Anand S S; Malmberg K; Weitz J I; Ginsberg J S; Yusuf S
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.
Lancet 2000;355(9219):1936-42.
2000: Flather M D; Yusuf S; Køber L; Pfeffer M; Hall A; Murray G; Torp-Pedersen C; Ball S; Pogue J; Moyé L; Braunwald E
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
Lancet 2000;355(9215):1575-81.
2000: Connolly S J; Kerr C R; Gent M; Roberts R S; Yusuf S; Gillis A M; Sami M H; Talajic M; Tang A S; Klein G J; Lau C; Newman D M
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
The New England journal of medicine 2000;342(19):1385-91.
2000: Gerstein H C; Mann J F; Pogue J; Dinneen S F; Hallé J P; Hoogwerf B; Joyce C; Rashkow A; Young J; Zinman B; Yusuf S
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
Diabetes care 2000;23 Suppl 2():B35-9.
2000: Granger C B; Ertl G; Kuch J; Maggioni A P; McMurray J; Rouleau J L; Stevenson L W; Swedberg K; Young J; Yusuf S; Califf R M; Bart B A; Held P; Michelson E L; Sellers M A; Ohlin G; Sparapani R; Pfeffer M A
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: Yusuf S
Challenges in the conduct and interpretation of phase II (pilot) randomized trials.
American heart journal 2000;139(4):S136-42.
2000: Capes S E; Gerstein H C; Negassa A; Yusuf S
Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
Diabetes care 2000;23(3):377-80.
2000: Yusuf S; Dagenais G; Pogue J; Bosch J; Sleight P
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
The New England journal of medicine 2000;342(3):154-60.
2000: Yusuf S; Sleight P; Pogue J; Bosch J; Davies R; Dagenais G
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
The New England journal of medicine 2000;342(3):145-53.
1999: Anand S; Yusuf S
Cardiovascular diseases in ethnic groups.
The Canadian journal of cardiology 1999;15 Suppl G():47G-50G.
1999: Anand S S; Yusuf S
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
JAMA : the journal of the American Medical Association 1999;282(21):2058-67.
1999: Anand S S; Kundi A; Eikelboom J; Yusuf S
Low rates of preventive practices in patients with peripheral vascular disease.
The Canadian journal of cardiology 1999;15(11):1259-63.
1999: Yusuf S
Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
The American journal of cardiology 1999;84(5A):20M-25M.
1999: Piegas L S; Flather M; Pogue J; Hunt D; Varigos J; Avezum A; Anderson J; Keltai M; Budaj A; Fox K; Ceremuzynski L; Yusuf S
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina.
The American journal of cardiology 1999;84(5A):7M-12M.
1999: Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
Journal of cardiac failure 1999;5(3):276-82.
1999: McKelvie R S; Yusuf S; Pericak D; Avezum A; Burns R J; Probstfield J; Tsuyuki R T; White M; Rouleau J; Latini R; Maggioni A; Young J; Pogue J
Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
Circulation 1999;100(10):1056-64.
1999: Eikelboom J W; Lonn E; Genest J; Hankey G; Yusuf S
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
Annals of internal medicine 1999;131(5):363-75.
1999: Demers C; McKelvie R S; Yusuf S
The role of digitalis in the treatment of heart failure.
Coronary artery disease 1999;10(6):353-60.
1999: Yusuf S
Randomised controlled trials in cardiovascular medicine: past achievements, future challenges.
BMJ (Clinical research ed.) 1999;319(7209):564-8.
1999: Bart B A; Ertl G; Held P; Kuch J; Maggioni A P; McMurray J; Michelson E L; Rouleau J L; Warner Stevenson L; Swedberg K; Young J B; Yusuf S; Sellers M A; Granger C B; Califf R M; Pfeffer M A
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: Sheth T; Nair C; Nargundkar M; Anand S; Yusuf S
Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;161(2):132-8.
1999: Yusuf S; Lonn E; Bosch J; Gerstein H
Summary of randomized trials of angiotensin converting enzyme inhibitors.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(5-6):835-45.
1999: Wang Y; Flather M; Yusuf S; Wang Y H; Li L X; Wang Z C
Recurrent events in meta-analysis of multiple clinical trials.
Zhongguo yao li xue bao = Acta pharmacologica Sinica 1999;20(6):495-9.
1999: Sheth T; Nair C; Muller J; Yusuf S
Increased winter mortality from acute myocardial infarction and stroke: the effect of age.
Journal of the American College of Cardiology 1999;33(7):1916-9.
1999: McKelvie R S; Benedict C R; Yusuf S
Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.
BMJ (Clinical research ed.) 1999;318(7195):1400-2.
1999: Lonn E M; Yusuf S
Evidence based cardiology: emerging approaches in preventing cardiovascular disease.
BMJ (Clinical research ed.) 1999;318(7194):1337-41.
1999: Gerstein H C; Pais P; Pogue J; Yusuf S
Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study.
Journal of the American College of Cardiology 1999;33(3):612-9.
1999: Coutinho M; Gerstein H C; Wang Y; Yusuf S
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
Diabetes care 1999;22(2):233-40.
1999: Enas E A; Yusuf S
Third Meeting of the International Working Group on Coronary Artery Disease in South Asians. 29 March 1998, Atlanta, USA.
Indian heart journal 1999;51(1):99-103.
1998: Anand S S; Yusuf S; Vuksan V; Devanesen S; Montague P; Kelemen L; Bosch J; Sigouin C; Teo K K; Lonn E; Gerstein H C; Hegele R A; McQueen M
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.
The Canadian journal of cardiology 1998;14(11):1349-57.
1998: Yusuf S; Lonn E
Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
European heart journal 1998;19 Suppl J():J36-44.
1998: Anand S S; Yusuf S; Pogue J; Weitz J I; Flather M
Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
Circulation 1998;98(11):1064-70.
1998: Yusuf S; Flather M; Pogue J; Hunt D; Varigos J; Piegas L; Avezum A; Anderson J; Keltai M; Budaj A; Fox K; Ceremuzynski L
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.
Lancet 1998;352(9127):507-14.
1998: Pogue J; Yusuf S
Overcoming the limitations of current meta-analysis of randomised controlled trials.
Lancet 1998;351(9095):47-52.
1997: Yusuf S
Meta-analysis of randomized trials: looking back and looking ahead.
Controlled clinical trials 1997;18(6):594-601; discussion 661-6.
1997: Pogue J M; Yusuf S
Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis.
Controlled clinical trials 1997;18(6):580-93; discussion 661-6.
1997: Flather M D; Farkouh M E; Pogue J M; Yusuf S
Strengths and limitations of meta-analysis: larger studies may be more reliable.
Controlled clinical trials 1997;18(6):568-79; discussion 661-6.
1997: Sheth T; Nargundkar M; Chagani K; Anand S; Nair C; Yusuf S
Classifying ethnicity utilizing the Canadian Mortality Data Base.
Ethnicity & health 1997;2(4):287-95.
1997: Lonn E M; Yusuf S
Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
The Canadian journal of cardiology 1997;13(10):957-65.
1997: Anand S S; Pais P; Pogue J; Yusuf S
A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India.
Indian heart journal 1997;49(1):35-41.
1996: Yusuf S; Anand S; Avezum A; Flather M; Coutinho M
Treatment for acute myocardial infarction. Overview of randomized clinical trials.
European heart journal 1996;17 Suppl F():16-29.
1996: Gerstein H C; Bosch J; Pogue J; Taylor D W; Zinman B; Yusuf S
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.
Diabetes care 1996;19(11):1225-8.
1996: Lonn E M; Yusuf S; Doris C I; Sabine M J; Dzavik V; Hutchison K; Riley W A; Tucker J; Pogue J; Taylor W
Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.
The American journal of cardiology 1996;78(8):914-9.
1996: Venkatesh G; Fallen E L; Kamath M V; Connolly S; Yusuf S
Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.
Heart (British Cardiac Society) 1996;76(2):137-43.
1996: Connolly S J; Kerr C; Gent M; Yusuf S
Dual-chamber versus ventricular pacing. Critical appraisal of current data.
Circulation 1996;94(3):578-83.
1996: Pais P; Pogue J; Gerstein H; Zachariah E; Savitha D; Jayprakash S; Nayak P R; Yusuf S
Risk factors for acute myocardial infarction in Indians: a case-control study.
Lancet 1996;348(9024):358-63.
1996: Gerstein H C; Yusuf S
Dysglycaemia and risk of cardiovascular disease.
Lancet 1996;347(9006):949-50.
1995: Jha P; Flather M; Lonn E; Farkouh M; Yusuf S
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.
Annals of internal medicine 1995;123(11):860-72.
1995: Flather M D; Lonn E M; Yusuf S
Effects of ACE inhibitors on mortality when started in the early phase of myocardial infarction: evidence from the larger randomized controlled trials.
Journal of cardiovascular risk 1995;2(5):423-8.
1995: Avezum A; Flather M D; Yusuf S
Adjunctive therapy for myocardial infarction.
Arquivos brasileiros de cardiologia 1995;65(1):97-110.
1995: Rihal C S; Flather M; Hirsh J; Yusuf S
Advances in antithrombotic drug therapy for coronary artery disease.
European heart journal 1995;16 Suppl D():10-21.
1995: McKelvie R S; Teo K K; McCartney N; Humen D; Montague T; Yusuf S
Effects of exercise training in patients with congestive heart failure: a critical review.
Journal of the American College of Cardiology 1995;25(3):789-96.
1995: Avezum A; Pais P; Flather M D; Anand S; Yusuf S
Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
Indian heart journal 1995;47(2):95-105.
1994: Lonn E M; Yusuf S; Jha P; Montague T J; Teo K K; Benedict C R; Pitt B
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Circulation 1994;90(4):2056-69.
1994: McKelvie R; McConachie D; Yusuf S
Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
European heart journal 1994;15 Suppl B():9-13; discussion 26-30.
1994: Avezum A; Flather M; Yusuf S
Recent advances and future directions in myocardial infarction.
Cardiology 1994;84(6):391-407.
1993: Le Feuvre C; Yusuf S; Flather M; Farkouh M
Maximizing benefits of therapies in acute myocardial infarction.
The American journal of cardiology 1993;72(19):145G-155G.
1993: Yusuf S
Reduced mortality and morbidity with the use of angiotensin-converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
Herz 1993;18 Suppl 1():444-8.
1993: Yusuf S; Venkatesh G; Teo K K
Critical review of the approaches to the prevention of sudden death.
The American journal of cardiology 1993;72(16):51F-58F.
1993: Yusuf S; Lessem J; Jha P; Lonn E
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(4):S61-73.
1993: Yusuf S; Garg R; McConachie D
Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
Journal of cardiovascular pharmacology 1993;22 Suppl 9():S28-35.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Salim Yusuf

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Salim Yusuf (preview)

All Publications